The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability

Konstas A. G., Labbe A., Katsanos A., Meier-Gibbons F., Irkec M., Boboridis K. G., ...More

EXPERT OPINION ON DRUG SAFETY, vol.20, no.4, pp.453-466, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 20 Issue: 4
  • Publication Date: 2021
  • Doi Number: 10.1080/14740338.2021.1873947
  • Journal Name: EXPERT OPINION ON DRUG SAFETY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, EMBASE, MEDLINE
  • Page Numbers: pp.453-466
  • Keywords: BAK, benzalconium chloride, dry eye, glaucoma, intraocular pressure, IOP, ocular surface, ocular surface disease, OSD, preservative-free, OCULAR SURFACE DISEASE, BENZALKONIUM CHLORIDE, HYPERTENSION, COMBINATION, PREVALENCE, SYMPTOMS, ANALOGS, SIGNS, EYE
  • Hacettepe University Affiliated: Yes

Abstract

Introduction: Preservative-free (PF) medications represent a valuable treatment strategy in the lifelong management of glaucoma. By removing preservative toxicity, PF formulations provide tangible clinical benefits to glaucoma patients worldwide. They improve tolerability and adherence, leading to a positive impact in long-term intraocular pressure (IOP) control.